EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H40N8O3S |
| Net Charge | 0 |
| Average Mass | 580.759 |
| Monoisotopic Mass | 580.29441 |
| SMILES | COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1 |
| InChI | InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
| InChIKey | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 6.1.1.6 (lysine--tRNA ligase) inhibitor An EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor that specifically inhibits the action of lysine-tRNA ligase (EC 6.1.1.6). EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ASP-3026 (CHEBI:167650) has role antimalarial (CHEBI:38068) |
| ASP-3026 (CHEBI:167650) has role antineoplastic agent (CHEBI:35610) |
| ASP-3026 (CHEBI:167650) has role apoptosis inducer (CHEBI:68495) |
| ASP-3026 (CHEBI:167650) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| ASP-3026 (CHEBI:167650) has role EC 6.1.1.6 (lysine—tRNA ligase) inhibitor (CHEBI:167677) |
| ASP-3026 (CHEBI:167650) is a N-methylpiperazine (CHEBI:46920) |
| ASP-3026 (CHEBI:167650) is a aromatic amine (CHEBI:33860) |
| ASP-3026 (CHEBI:167650) is a diamino-1,3,5-triazine (CHEBI:38170) |
| ASP-3026 (CHEBI:167650) is a monomethoxybenzene (CHEBI:25235) |
| ASP-3026 (CHEBI:167650) is a piperidines (CHEBI:26151) |
| ASP-3026 (CHEBI:167650) is a secondary amino compound (CHEBI:50995) |
| ASP-3026 (CHEBI:167650) is a sulfone (CHEBI:35850) |
| IUPAC Name |
|---|
| N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propan-2-ylsulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
| Synonyms | Source |
|---|---|
| 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine | ChEBI |
| Asp-3026 | ChEMBL |
| ASP 3026 | ChemIDplus |
| ASP3026 | ChemIDplus |
| N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:1097917-15-1 | ChemIDplus |
| Citations |
|---|